AFC-HD AMS Life Science Co., Ltd. logo

AFC-HD AMS Life Science Co., Ltd.

2927.T

JPXConsumer DefensivePackaged Foods

Latest quote

¥901

¥0.00 · 0.00%

Aug 24, 1:25 PM JST

2927.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

AFC-HD AMS Life Science Co., Ltd. operates as an original equipment manufacturer of health foods and cosmetics. The company operates through five segments: Healthcare, Pharmaceutical, Department Store, Food and Beverage, and Other Business. The Healthcare segment manufactures, sells, and supplies OEM health foods, such as tablets, capsules, granules, soft drinks, and jelly; and cosmetics, including skin care and hair care products. This segment also operates as an advertising agency focused on planning and producing health information programs, and publishing health information magazines. The Pharmaceutical segment manufactures and sells Chinese herbal medicine, over-the-counter medicines, and generic medicines. The Department Store segment engages in the wholesale of watches, jewelry, and precious metal products. The Food and Beverage segment operates restaurants. The Other Business segment engages in the real estate buying, selling, management, rental, and intermediary business; construction industry; tourism, travel and hotel industry; and school lunch business. AFC-HD AMS Life Science Co., Ltd. was founded in 1969 and is headquartered in Shizuoka, Japan.

Industry
Packaged Foods
Sector
Consumer Defensive
Headquarters
JP
CEO
Tsunenori Nishikiori
Listed since
Mar 3, 2005
Employees
1,008

Market position

Day range

Current ¥901

52-week range

Current ¥901

Open
¥898
Previous close
¥901
Volume
17.4K
0.63× average
Average volume
27.73K
Average daily volume
Market cap
13.12B JPY
Beta
0.51
Market reference 1
50-day average
¥856.5
+5.20% above average
200-day average
¥869.81
+3.59% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

P/E (TTM)
10.79×
P/B (TTM)
0.81×
P/S (TTM)
0.4×
Dividend yield
4.00%

Profitability & efficiency

Gross margin
34.19%
Operating margin
7.10%
Net margin
3.62%

Financial health

Debt / equity
1.47×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends41%27%13%-0%Gross margin, FY2021: 30.69%Gross margin, FY2022: 37.30%Gross margin, FY2023: 36.45%Gross margin, FY2024: 34.76%Gross margin, FY2025: 33.59%Operating margin, FY2021: 10.04%Operating margin, FY2022: 4.41%Operating margin, FY2023: 6.40%Operating margin, FY2024: 6.35%Operating margin, FY2025: 7.29%Net margin, FY2021: 6.69%Net margin, FY2022: 3.20%Net margin, FY2023: 4.31%Net margin, FY2024: 4.15%Net margin, FY2025: 4.44%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 30.69%. Gross margin FY2022 37.30%. Gross margin FY2023 36.45%. Gross margin FY2024 34.76%. Gross margin FY2025 33.59%. Operating margin FY2021 10.04%. Operating margin FY2022 4.41%. Operating margin FY2023 6.40%. Operating margin FY2024 6.35%. Operating margin FY2025 7.29%. Net margin FY2021 6.69%. Net margin FY2022 3.20%. Net margin FY2023 4.31%. Net margin FY2024 4.15%. Net margin FY2025 4.44%.

Income trends

Revenue

32.66B JPY+8.18%

Operating income

2.38B JPY+24.21%

Net income

1.45B JPY+15.69%
Income trends across reported periods35.85B JPY23.08B JPY10.31B JPY−2.46B JPYRevenue, FY2021: 22.37B JPYRevenue, FY2022: 23B JPYRevenue, FY2023: 25.58B JPYRevenue, FY2024: 30.19B JPYRevenue, FY2025: 32.66B JPYOperating income, FY2021: 2.25B JPYOperating income, FY2022: 1.02B JPYOperating income, FY2023: 1.64B JPYOperating income, FY2024: 1.92B JPYOperating income, FY2025: 2.38B JPYNet income, FY2021: 1.5B JPYNet income, FY2022: 735.35M JPYNet income, FY2023: 1.1B JPYNet income, FY2024: 1.25B JPYNet income, FY2025: 1.45B JPYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 22.37B JPY. Revenue FY2022 23B JPY. Revenue FY2023 25.58B JPY. Revenue FY2024 30.19B JPY. Revenue FY2025 32.66B JPY. Operating income FY2021 2.25B JPY. Operating income FY2022 1.02B JPY. Operating income FY2023 1.64B JPY. Operating income FY2024 1.92B JPY. Operating income FY2025 2.38B JPY. Net income FY2021 1.5B JPY. Net income FY2022 735.35M JPY. Net income FY2023 1.1B JPY. Net income FY2024 1.25B JPY. Net income FY2025 1.45B JPY.
Metric (JPY)FY2025FY2024FY2023FY2022FY2021
Revenue32.66B JPY30.19B JPY25.58B JPY23B JPY22.37B JPY
Cost of goods sold21.68B JPY19.69B JPY16.26B JPY14.42B JPY15.5B JPY
Gross profit10.97B JPY10.49B JPY9.32B JPY8.58B JPY6.87B JPY
Research and development143.12M JPY148M JPY145.06M JPY153.03M JPY163.7M JPY
Selling, general, and administrative8.39B JPY8.35B JPY7.53B JPY7.26B JPY4.42B JPY
Operating expenses8.59B JPY8.58B JPY7.69B JPY7.57B JPY4.62B JPY
Interest income10.78M JPY2.46M JPY4.19M JPY4.06M JPY3.47M JPY
Interest expense201.23M JPY101.27M JPY57.56M JPY57.59M JPY50.04M JPY
Depreciation and amortization1.4B JPY1.09B JPY984M JPY1.01B JPY649.88M JPY
Operating income2.38B JPY1.92B JPY1.64B JPY1.02B JPY2.25B JPY
Net income1.45B JPY1.25B JPY1.1B JPY735.35M JPY1.5B JPY

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
25.06

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates40.5927.7814.982.18Q4 '24Q1 '25Q2 '25Q3 '25Q3 '25Q1 '26Q2 '26Q3 '26
Q4 2024, reported Oct 15, 2024: actual 22.86, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Jan 14, 2025: actual 32.7, estimate —, surprise —, Comparison unavailable. Q2 2025, reported Apr 14, 2025: actual 29.96, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Jul 14, 2025: actual 37.77, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 31, 2025: actual 2.56, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Jan 14, 2026: actual 36.7, estimate —, surprise —, Comparison unavailable. Q2 2026, reported Apr 14, 2026: actual 19.06, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Jul 15, 2026: actual 25.06, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly Revenue actual values compared with estimates8.89B8.43B7.96B7.5BQ4 '24Q1 '25Q2 '25Q3 '25Q3 '25Q1 '26Q2 '26Q3 '26
Q4 2024, reported Oct 15, 2024: actual 7.84B JPY, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Jan 14, 2025: actual 8.19B JPY, estimate —, surprise —, Comparison unavailable. Q2 2025, reported Apr 14, 2025: actual 8.42B JPY, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Jul 14, 2025: actual 8.12B JPY, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 31, 2025: actual 7.92B JPY, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Jan 14, 2026: actual 8.55B JPY, estimate —, surprise —, Comparison unavailable. Q2 2026, reported Apr 14, 2026: actual 8.3B JPY, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Jul 15, 2026: actual 8.43B JPY, estimate —, surprise —, Comparison unavailable.

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

¥34.00

2025 complete year+23.6% since 2021

2026 partial: ¥18.00

* Partial calendar year in the available dividend history.

Corporate action history

DividendUpcoming

Ex-dividend Aug 28, 2026

¥22.00

Semi-Annual

Record Aug 31, 2026 · Payment Aug 28, 2026

Dividend

Ex-dividend Feb 26, 2026

¥18.00

Semi-Annual

Record Feb 28, 2026 · Payment May 21, 2026

Dividend

Ex-dividend Aug 28, 2025

¥18.00

Semi-Annual

Record Aug 31, 2025 · Payment Nov 28, 2025

Dividend

Ex-dividend Feb 27, 2025

¥16.00

Semi-Annual

Record Feb 28, 2025 · Payment May 19, 2025

Dividend

Ex-dividend Aug 29, 2024

¥15.00

Semi-Annual

Record Aug 31, 2024 · Payment Nov 27, 2024

Dividend

Ex-dividend Feb 28, 2024

¥15.00

Semi-Annual

Record Feb 29, 2024 · Payment May 17, 2024

2927.T peers

ETFs holding 2927.T

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research 2927.T

research.disclaimer